丹参酮ⅡA和隐丹参酮近红外光谱的2D-COS解析及其在丹参酮提取物近红外模型中应用

采用二维相关光谱（2D-COS）技术,以氘代氯仿为溶剂,解析了丹参酮ⅡA和隐丹参酮标准品的近红外光谱（NIR）。丹参酮ⅡA和隐丹参酮二维相关切片谱在1 600~1 800,1 900~2 230和2 300~2 400 nm处有特征吸收,其中丹参酮ⅡA在1 640和2 140 nm处有不同于隐丹参酮的呋喃环双键一级倍频和组合频吸收,1 696 nm为丹参酮ⅡA和隐丹参酮分子中甲基伸缩振动二级倍频,1 726和1 740 nm处吸收为丹参酮ⅡA和隐丹参酮环己烯亚甲基伸缩振动二级倍频,2 146和2 220 nm为丹参酮ⅡA和隐丹参酮苯环C—C伸缩振动与C—H伸缩振动的组合频,2 300～2 400 nm处一系列峰为丹参酮ⅡA和隐丹参酮甲基伸缩振动与弯曲振动组合频吸收。以丹参酮提取物为载体,以丹参酮ⅡA和隐丹参酮光谱解析特征波段及组合间隔偏最小二乘（SiPLS）筛选特征波段分别建立偏最小二乘（PLS）定量模型,模型的决定系数R2均大于0.9,校正均方根误差（root mean of square error of calibration, RMSEC）和交叉验证均方根误差（RMSECV）,预测均方根误差（RMSEP）均较小。结果表明,2D-COS技术解析特征波段与SiPLS波段筛选所建PLS模型均稳定。2D-COS技术使近红外定量模型更具解释性,可解析出结构差异特征吸收,同一波段可实现结构类似物的同时定量测定。     

微乳介质中丹参酮ⅡA与牛血清白蛋白的相互作用

在以微乳液为共溶介质的缓冲体系中,用紫外光谱法研究了丹参酮ⅡA与牛血清白蛋白(BSA)的相互作用.结果表明:丹参酮ⅡA在中性条件下与牛血清白蛋白(BSA)结合,结合后吸光强度增加,用Scatchard方程求得二者在微乳体系中的结合常数,推测丹参酮ⅡA与牛血清白蛋白的作用机制可能为疏水力作用.     

pH对隐丹参酮和丹参酮A的荧光特性及分子结构影响研究

考察研究了丹参主要有效成分隐丹参酮和丹参酮 A在不同酸性介质中的荧光特性。结果表明隐丹参酮和丹参酮 A均有很宽的 p H发光范围 ( p H=1- 11)。在 p H=2 - 3时 ,隐丹参酮和丹参酮 A荧光发射最强。在强酸 ( 5mol/L HCl)和强碱 ( 2 mol/L Na OH)介质中隐丹参酮和丹参酮 A的荧光均被显著猝灭 ,同时荧光光谱发生明显蓝移。表明隐丹参酮和丹参酮 A在强酸强碱下分子结构发生了明显变化。从而为它们的药理及其理化性质等的研究提供了分子结构信息等的依据     

pH对隐丹参酮和丹参酮ⅡA的荧光特性及分子结构影响研究

考察研究了丹参主要有效成分隐丹参酮和丹酮ⅡＡ在不同酸性介质中的荧光特性,结果表明,隐丹酮和丹参酮ⅡＡ均有很宽的ＰＨ发光范围。在ＰＨ＝２－３时,隐丹参酮和丹参酮ⅡＡ荧光发射最强。在强酸（５ｍｏｌ／ＬＨＣｌ）和强碱（２ｍｏｌ／ＬＮａＯＨ）介质中庆参酮和丹参酮ⅡＡ（的荧光均被显著猝灭,同时荧光光谱发生明显蓝移。表明隐丹参酮和参酮ⅡＡ在强酸强碱下分子结构发生了明显变化,从而为它们的药理及其理化性质等的提供     

丹参酮ⅡA及丹参酮ⅡA-Cu(Ⅱ)配合物的分子结构和电子吸收光谱研究

用ICCD瞬态光谱探测系统,检测了乙醇溶剂中丹参酮ⅡA及其与Cu(Ⅱ)形成的配合物的紫外-可见吸收光谱。采取密度泛函(DFT)方法优化几何构型,获得了丹参酮ⅡA及丹参酮ⅡA-Cu(Ⅱ)配合物的稳定几何结构。在此基础上,运用含时密度泛函(TD-DFT)方法,计算了丹参酮ⅡA及丹参酮ⅡA-Cu(Ⅱ)配合物的气相和乙醇溶剂(PCM)中的电子吸收光谱。结果表明,乙醇溶剂效应使丹参酮ⅡA的吸收光谱红移,配合物的吸收光谱蓝移。计算得到的溶液相丹参酮ⅡA及丹参酮ⅡA-Cu(Ⅱ)配合物电子吸收光谱与实验测量光谱符合较好。本文首次测量和计算得到了丹参酮ⅡA与Cu(Ⅱ)形成的配合物的电子吸收光谱。     

丹参超微粉碎前后丹参酮ⅡA的溶出行为比较

采用高效液相色谱法测定丹参超微粉体和常规粉体中丹参酮ⅡA体外溶出量和溶出速率.丹参超微粉体和常规粉体中丹参酮ⅡA体外溶出量无显著性差异,超微粉体的溶出速率较常规粉体明显增加.实验表明超微粉碎可明显提高丹参酮ⅡA溶出速率.     

高效液相色谱法测定复方丹参滴丸中的丹参酮ⅡA

建立了测定丹参酮ⅡA含量的高效液相色谱(HPLC)方法.方法采用Eclipse Plus C18柱(250mm×4.6mm,5μm)色谱柱,流动相为70％的乙腈水溶液,流速为1.0mL·min-1,检测波长268nm,柱温为室温,进样量为20μL.丹参酮ⅡA在1.65×10-4-1.0g·L-1范围内与峰面积呈现良好的线性关系(r=0.9984),检出限为5.7×10-5g· L-1.所建立的方法简单、灵敏度高、重现性好,可用于制剂中丹参酮ⅡA含量的测定.     

两种丹参酮化合物分子的荧光特性及分析方法的研究

本文研究了丹参酮主要成分中的隐丹参酮 (CTSS)、丹参酮 A(TSS A)的荧光光谱特性 ,讨论了酸度、光照时间、温度等因素对荧光强度的影响。建立了 CTSS、TSS A的荧光分析方法。方法的相对标准偏差 (RSD)分别为 0 .2 2 %和 0 .15 % ,检出限均能达到 1× 10 -6mol/ L。     

光谱法和分子对接方法研究罗利环素与人血清白蛋白的相互作用（英文）

在模拟人体生理条件下,应用多光谱法和分子对接技术对罗利环素(RTC)与人血清白蛋白(HSA)的相互作用进行了研究。实验通过消除内滤光来提高荧光数据的准确性。此外,荧光光谱和紫外光谱的结果表明RTC与HSA的猝灭方式是静态猝灭,且在298和310K温度下的结合位点数分别为1.09和0.95。在两个不同温度下的结合常数分别为K298K=3.13×105 L·mol-1和K310K=0.70×105 L·mol-1。根据热力学参数的计算结果可知,RTC与HSA的结合作用力主要是氢键和范德华力。取代实验表明,RTC在HSA的SiteⅠ,ⅡA子域上有一个结合位点。根据非辐射能量转移理论得到的RTC和HSA氨基酸残基间的结合距离为2.59nm。三维荧光光谱表明RTC和HSA的相互作用改变了蛋白质的构象。此外,采用傅里叶变换红外光谱法对RTC与HSA作用前后HSA二级结构的变化进行了定量分析,结果表明,α-螺旋结构含量降低了8.4%,β-折叠含量从30.3%增加到31.4%,β-转角也从15.6%增加到了16.1%。分子对接进一步显示RTC通过氢键、疏水作用力、极性键等多种作用力与HSA的ⅡA子域上氨基酸残基相互作用。实验结果有助于从分子水平研究RTC和HSA的相互作用。     

光谱法和分子对接法研究和比较两种全氟羧酸与人血清白蛋白的结合模式

全氟羧酸(PFCAs)由于具有既亲水又疏水的表面活性剂特性,被广泛应用于工业和生活产品中。全氟十一酸(PFUnA)和全氟十三酸(PFTriA)是长链 PFCAs 类的典型代表,但近年来它们越来越频繁的在人体中检测到,并且发现表现出内分泌干扰效应、发育毒性和致畸性。本文以光谱学和分子对接为基础,探索 PFUnA 和 PFTriA 与人体最丰富的蛋白人血清白蛋白(HSA)的结合模式。结果表明,PFUnA 和 PFTriA均通过动静态猝灭过程猝灭 HSA 的内源荧光,与 HSA 只有一个强亲和位点,且 PFUnA 与 HSA 的结合比PFTriA 更紧密。根据热力学计算结果,可知 PFUnA 与 HSA 结合的焓变、熵变分别为-26.32 kJ·mol-1和21.76 J·mol-1·K-1,其结合作用主要依靠静电引力,而 PFTriA 主要通过范德华力和卤键与 HSA 结合,是放热熵减过程,其焓变和熵变分别为-39.69 kJ·mol-1和-25.66 J·mol-1·K-1。计算得到的结合距离(r<8 nm)显示从 HSA 到 PFUnA 和 PFTriA 发生了非辐射能量转移。三维荧光光谱和圆二色谱表明,PFU-nA 和 PFTriA 与 HSA 的结合不仅可以改变 HSA 的构象和微环境,还可以引起α-螺旋稳定性降低。取代实验和分子对接进一步显示 PFUnA 和 PFTriA 通过极性键、疏水作用力和卤键等与 HSA 的亚域ⅡA 疏水腔有高亲和性,且荧光团 Trp 残基处于结合位置中,进一步证明 PFUnA 和 PFTriA 可以猝灭 HSA 的荧光。本文研究结果为阐明长链 PFCAs 在机体内与血清蛋白的结合机理提供了完整可靠的数据,并为长链 PFCAs的毒性评价和毒理学研究提供了理论依据。     

Optical, Structural and Thermodynamic Studies of the Association of an Anti-leucamic Drug Imatinib Mesylate with Transport Protein

The interaction of an anti-leukemic drug, imatinib mesylate (IMT) with human serum albumin (HSA) was investigated by fluorescence, synchronous fluorescence, three-dimensional fluorescence, circular dichroism and UV–vis absorption techniques under physiological condition. The process of binding of IMT on HSA was observed to be through a spontaneous molecular interaction procedure. IMT effectively quenched the intrinsic fluorescence of HSA via static quenching. The values of binding constant, number of molecules that interact simultaneously with the binding site and thermodynamic parameters were evaluated by carrying out the interactions at three different temperatures. Based on thermodynamic parameters and displacement studies with site probes, it was proposed that the drug bound at Sudlow’s site I of subdomain IIA. The change in the conformation of HSA was evident from synchronous, three-dimensional fluorescence and circular dichroism studies. The distance between the donor (protein) and acceptor (drug) was calculated based on the Foster’s theory of resonance energy stransfer and it was found to be 1.30 nm. The effect of different metal ions on the binding of the drug to protein was also investigated.     

Studies on the interaction between scopoletin and two serum albumins by spectroscopic methods

The interactions of scopoletin to bovine serum albumin (BSA) and human serum albumin (HSA) have been investigated by spectroscopic methods. The fluorescence tests indicated that the formation mechanism of scopoletin–BSA/HSA complexes belonged to the static quenching. The displacement experiments suggested that scopoletin primarily bound to tryptophan residues of BSA/HSA within site I (subdomain IIA). The binding distance of scopoletin to BSA/HSA was 2.38/2.34 nm. The thermodynamic parameters (ΔG, ΔH and ΔS) calculated on the basis of different temperatures revealed that the binding of BSA–scopoletin was mainly depended on van der Waals interaction and hydrogen bond, and yet the binding of HSA–scopoletin was strongly relied on the hydrophobic interaction and electrostatic interaction. The results of synchronous fluorescence, 3D fluorescence, UV–vis absorption, and FT-IR spectra showed that the conformations of BSA and HSA altered with the addition of scopoletin. In addition, the effects of some common ions on the binding constants of scopoletin to proteins were also investigated.     

三种异黄酮类药物与不同异构体人血清白蛋白的作用机制研究

利用荧光光谱研究了三种异黄酮类化合物染料木素、鸡豆黄素A和3’,4’,7-三羟基异黄酮与不同异构体人血清白蛋白的相互作用机制。计算了异黄酮与蛋白质形成复合物的各种结合参数(猝灭速率常数、结合常数及结合位点数),结果表明三种异黄酮类化合物在人血清白蛋白上只有一个结合位点,位于结合位点siteⅠ,结合常数在0.17×105～1.20×105 L.mol-1之间。荧光增强光谱结果显示,与蛋白质作用后药物的荧光强度明显增加,说明了药物与人血清白蛋白发生了结合,在此基础上讨论了三种异黄酮与人血清白蛋白的结合机理。     

Transport of a Cancer Chemopreventive Polyphenol,Resveratrol: Interaction with Serum Albumin and Hemoglobin

Resveratrol is a natural phytoalexin with pharmacologic effects on several human diseases: carcinogenesis, coronary heart disease and neurodegenerative disease. Due to its poor water solubility, resveratrol must be bound to proteins to keep it at a high concentration in serum. In our work, the bindings of resveratrol to plasma proteins, human serum albumin (HSA) and hemoglobin (Hb), have been investigated systematically by fluorescence quenching technique, synchronous fluorescence, UV–vis absorption spectroscopy, circular dichroism (CD) spectroscopy and molecular modeling method. The fluorescence data show that the binding of resveratrol to HSA or Hb is a static quenching procedure and each protein has only one binding site for the drug. The binding constant of resveratrol to HSA is larger than that of resveratrol to Hb at corresponding temperature, which indicates that the affinity of HSA toward the drug is higher than that of Hb. The CD spectroscopy indicates that the secondary structures of the proteins are changed in the presence of resveratrol with the reduction of α-helices, which decreased about 18.75% for HSA and 9.43% for Hb at the drug to proteins molar ratio of 2. Thermodynamic analysis and molecular modeling suggest that hydrophobic interaction plays a major role in the binding of resveratrol to HSA, and hydrogen bonding is the mainly binding force in the binding of resveratrol to Hb. The study of molecular modeling shows that resveratrol is located in the hydrophobic cavity between subdomain IB and IIA of HSA (the entrance of site I), or located in the central cavity of Hb (partial to the subunit A).     

光谱法联合分子对接和等温滴定微量热法研究全氟壬酸与人血清白蛋白的相互作用

全氟壬酸(PFNA)是在血清中检测到第三多的全氟烷酸类(PFAAs)新型有毒环境污染物。目前PF-NA对人血清白蛋白(HSA)结构甚至是功能的影响还处于起步阶段,借助于多光谱、分子对接和等温滴定微量热(ITC)技术研究了PFNA和 HSA相互作用的结合机理。所有荧光数据均进行了内滤光校正以获得更准确的结合参数。荧光结果表明PFNA通过动静态猝灭方式可以猝灭 HSA的内源荧光。取代实验和分子对接结果表明,PFNA主要通过极性键、疏水力和卤素键键合在 HSA 亚域ⅡA 疏水腔中,最佳对接自由能为-26.54 kJ·mol-1,表明PFNA分子与HSA有较大的结合亲和力。ITC表明两者的结合属于两类结合位点模型并给出了相应的热力学参数：第一类结合位点有较大的亲和力,属于焓驱动,静电力和卤键作为主要驱动力;第二类结合位点亲和力较小,主要驱动力是疏水力。三维荧光光谱揭示 PFNA 与 HSA 生成复合物后,可以改变 HSA 的构象,引起 Trp 和 Tyr 残基微环境疏水性增强。圆二色谱(CD)定量测定了 HSA 与P F N A作用前后的二级结构含量：α-螺旋、β-折叠和β-转角含量分别降低14.3%,5.3%和3.5%,无规卷曲含量从14.4%增加到37.5%。以上结果表明,PFNA与 HSA的结合可以改变 HSA的二级结构,进而可能影响 HSA的生理功能。结果阐述了PFNA与 HSA相互作用机理,并且为PFNA在体内的运输和分配提供了可靠的生物物理和生物化学的相关依据。     

Characterization of Interaction Between Bergenin and Human Serum Albumin in Membrane Mimetic Environments

The interaction between bergenin and human serum albumin (HSA) in AOT/isooctane/water microemulsions was studied by fluorescence quenching technique in combination with UV absorption spectroscopy, circular dichroism (CD) spectroscopy and dynamic light scattering (DLS) technique. Fluorescence data in omega (o) 20 microemulsions revealed the presence of a binding site of bergenin on HSA and its binding constants (K) were 1.64 x 10(4), 1.44 x 10(4), 1.26 x 10(4) and 1.09 x 10(4) M(-1) at 289, 296, 303, and 310 K, respectively. The binding of bergenin with HSA in microemulsions was stronger than that in buffer solution. The alterations of protein secondary structure in the microemulsions in the absence and presence of bergenin compared with the free form of HSA in buffer were qualitatively and quantitatively analyzed by the evidence from CD spectra. Enthalpy and entropy changes for the reaction were calculated to be -14.45 kJ mol(-1) and 30.76 J mol(-1) K(-1). These results indicated that bergenin bound to HSA mainly by a hydrophobic interaction in microemulsions which was in agreement with the result of the molecular modeling study. The DLS data suggested that HSA may locate at the interface of the microemulsion and bergenin could interact with them.     

多光谱法和分子对接研究α-熊果苷与人血清白蛋白的相互作用

α-熊果苷是一种能够止咳平喘的植物提取物，有关它与蛋白质的相互作用及作用机理报道较少。应用光谱学与分子对接技术研究了在不同条件下α-熊果苷与人血清白蛋白（HSA）的相互作用。研究结果显示：随着α-熊果苷浓度的增大，HSA荧光强度得到了显著增强并且荧光光谱发生了蓝移。利用荧光增敏的各种有关方程求得了α-熊果苷在不同温度下与HSA作用的结合常数, 通过范特霍夫方程计算HSA与α-熊果苷相互作用过程中的ΔH=-23.29 kJ·mol-1和ΔS=40.96 J·mol-1·K-1，说明α-熊果苷与HSA之间的主要作用力是氢键和疏水作用力。通过紫外吸收光谱、同步荧光光谱、三维荧光光谱等光谱学方法研究发现α-熊果苷使HSA的构象发生改变。通过HSA与α-熊果苷作用前后圆二色二级结构的定量分析可得知，HSA与α-熊果苷复合物的形成使蛋白质螺旋稳定性降低。最后应用分子对接实验，验证了α-熊果苷与HSA间的相互作用位点在HSA的siteⅡ（亚域ⅢA），α-熊果苷能通过氢键和疏水作用力等多种作用力很好的结合在亚域ⅢA的疏水腔中。从实验中获得的数据能够阐明α-熊果苷对HSA的作用机制，同时能够有助于理解α-熊果苷在人体的储藏运输过程中对蛋白质功能的影响。     

光谱法和分子对接方法研究罗利环素与人血清白蛋白的相互作用

在模拟人体生理条件下，应用多光谱法和分子对接技术对罗利环素(RTC)与人血清白蛋白(HSA)的相互作用进行了研究。实验通过消除内滤光来提高荧光数据的准确性。此外，荧光光谱和紫外光谱的结果表明RTC与HSA的猝灭方式是静态猝灭，且在298和310 K温度下的结合位点数分别为1.09和0.95。在两个不同温度下的结合常数分别为K_{298 K}=3.13×105 L·mol-1和K_{310 K}=0.70×105 L·mol-1。根据热力学参数的计算结果可知，RTC与HSA的结合作用力主要是氢键和范德华力。取代实验表明，RTC在HSA的Site Ⅰ，ⅡA子域上有一个结合位点。根据非辐射能量转移理论得到的RTC和HSA氨基酸残基间的结合距离为2.59 nm。三维荧光光谱表明RTC和HSA的相互作用改变了蛋白质的构象。此外，采用傅里叶变换红外光谱法对RTC与HSA作用前后HSA二级结构的变化进行了定量分析，结果表明，α-螺旋结构含量降低了8.4%，β-折叠含量从30.3%增加到31.4%，β-转角也从15.6%增加到了16.1%。分子对接进一步显示RTC通过氢键、疏水作用力、极性键等多种作用力与HSA的ⅡA子域上氨基酸残基相互作用。实验结果有助于从分子水平研究RTC和HSA的相互作用。     

Characterization of the Binding of Metoprolol Tartrate and Guaifenesin Drugs to Human Serum Albumin and Human Hemoglobin Proteins by Fluorescence and Circular Dichroism Spectroscopy

The interactions of metoprolol tartrate (MPT) and guaifenesin (GF) drugs with human serum albumin (HSA) and human hemoglobin (HMG) proteins at pH?7.4 were studied by fluorescence and circular dichroism (CD) spectroscopy. Drugs quenched the fluorescence spectra of HSA and HMG proteins through a static quenching mechanism. For each protein-drug system, the values of Stern-Volmer quenching constant, bimolecular quenching constant, binding constant and number of binding site on the protein molecules were determined at 288.15, 298.15, 310.15 and 318.15 K. It was found that the binding constants of HSA-MPT and HSA-GF systems were smaller than those of HMG-MPT and HMG-GF systems. For both drugs, the affinity of HMG was much higher than that of HSA. An increase in temperature caused a negative effect on the binding reactions. The number of binding site on blood proteins for MPT and GF drugs was approximately one. Thermodynamic parameters showed that MPT interacted with HSA through electrostatic attraction forces. However, hydrogen bonds and van der Waals forces were the main interaction forces in the formation of HSA-GF, HMG-MPT and HMG-GF complexes. The binding processes between protein and drug molecules were exothermic and spontaneous owing to negative ?H and ?G values, respectively. The values of binding distance between protein and drug molecules were calculated from Förster resonance energy transfer theory. It was found from CD analysis that the bindings of MPT and GF drugs to HSA and HMG proteins altered the secondary structure of HSA and HMG proteins.     

血卟啉与人血清白蛋白结合作用特征的热力学研究

采用荧光光谱法和紫外-可见吸收光谱法研究了在模拟人体生理条件下不同温度时,血卟啉与人血清白蛋白结合反应的荧光猝灭光谱行为,根据Stern-Volmer方程和Lineweaver-Burk双倒数函数曲线计算了其结合常数在高温时要比低温时小;根据Fφster能量传递原理计算出结合位点r=4.36,并根据热力学参数确定了它们之间的作用力类型主要为氢键和VanderWaals力,HP进入了HSA的疏水腔。